D.E. Shaw & Co’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-24,895
| Closed | -$119K | – | 2894 |
|
|
2019
Q2 | $119K | Sell |
24,895
-110,648
| -82% | -$529K | ﹤0.01% | 2474 |
|
|
2019
Q1 | $741K | Buy |
135,543
+65,480
| +93% | +$358K | ﹤0.01% | 1971 |
|
|
2018
Q4 | $213K | Buy |
70,063
+30,724
| +78% | +$93.4K | ﹤0.01% | 2358 |
|
|
2018
Q3 | $165K | Buy |
+39,339
| New | +$165K | ﹤0.01% | 2404 |
|
|
2017
Q3 | – | Sell |
-2,398
| Closed | -$23K | – | 2716 |
|
|
2017
Q2 | $23K | Sell |
2,398
-7,053
| -75% | -$67.6K | ﹤0.01% | 2378 |
|
|
2017
Q1 | $229K | Buy |
9,451
+8,025
| +563% | +$194K | ﹤0.01% | 2246 |
|
|
2016
Q4 | $46K | Sell |
1,426
-1,701
| -54% | -$54.9K | ﹤0.01% | 2447 |
|
|
2016
Q3 | $156K | Buy |
+3,127
| New | +$156K | ﹤0.01% | 2363 |
|
|
2015
Q4 | – | Sell |
-5,232
| Closed | -$350K | – | 2854 |
|
|
2015
Q3 | $350K | Buy |
+5,232
| New | +$350K | ﹤0.01% | 2184 |
|
|
2015
Q1 | – | Sell |
-8,686
| Closed | -$772K | – | 2773 |
|
|
2014
Q4 | $772K | Sell |
8,686
-12,884
| -60% | -$1.15M | ﹤0.01% | 1818 |
|
|
2014
Q3 | $1.49M | Buy |
+21,570
| New | +$1.49M | ﹤0.01% | 1366 |
|
|
2014
Q1 | – | Sell |
-2,683
| Closed | -$113K | – | 2703 |
|
|
2013
Q4 | $113K | Sell |
2,683
-228
| -8% | -$9.6K | ﹤0.01% | 2373 |
|
|
2013
Q3 | $87K | Buy |
2,911
+1,405
| +93% | +$42K | ﹤0.01% | 2306 |
|
|
2013
Q2 | $80K | Buy |
+1,506
| New | +$80K | ﹤0.01% | 2283 |
|